CXO Digital Transformation

Road to Relevant, Profitable, and Future-ready Pharma

Road to Relevant, Profitable, and Future-ready Pharma

The pharma companies are juggling multiple priorities like improving R&D, establishing a presence in global markets, and investing in digital transformation initiatives to move beyond the pill, find new revenue streams, and handle changing customer’s expectations for personalization. Pandemic further complicated the issues with delayed product launches, reduced in-person sales visit potential, supply chain disruption, and delays in drug commercialization. So how are the pharma industry players dealing with this perfect storm? What’s the road to relevant, profitable, and future-ready pharma?

Contributors

Minori Hara

Minori Hara, Chief Digital & Information Officer, Santen Pharmaceutical

Minori Hara is Chief Digital & Information Officer at Santen Pharmaceutical, a specialized company dedicated to ophthalmology. Santen carries out research, development, marketing, and sales of pharmaceuticals, over-the-counter products,... More   View all posts

Advertisement

Citrix MPU 300X250
Minori Hara

Login


Not Member Yet?
Register

Register

  • Name

  • Contact Info

  • About Yourself

  • Minimum length of 8 characters
  • Upload
  • Location

  • Professional Background

  • Other Social Profiles

  • Areas of Interest